White House Completes Review of Final Rule for 340B Dispute Process, Release Expected Soon

The Department of Health and Human Services is expected to soon release its final 340B administrative dispute resolution rule after the White House completed its final review this week.
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Asks Full Appeals Court to Rehear Arkansas 340B Contract Pharmacy Case

PhRMA has asked the full panel of judges on the U.S. 8th Circuit Court of Appeals to rehear a case on Arkansas' 340B contract pharmacy access law.
An influential drug industry trade group has asked a full federal appeals court to rehear a case on the constitutionality [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca’s Lawsuit Against Arkansas’ 340B Contract Pharmacy Law Reassigned to Judge Who Previously Upheld It

AstraZeneca's lawsuit challenging Arkansas' 340B contract pharmacy access law has been transferred to a federal judge who previously upheld it.
A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds Blood Therapy Drug to Hospital Contract Pharmacy Restrictions

Drugmaker Teva has added a blood therapy medication to its existing contract pharmacy restrictions for 340B hospitals.
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Stakeholders Clash on Patient Definition, 340B Spending Requirements in Comments on Senate ‘Group of Six’ Draft Overhaul

Advocacy groups for providers and drugmakers had diverging views in their comments on a draft Senate 340B overhaul.
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Officially Issues Contract Pharmacy Restrictions

Pharmaceutical manufacturer Genentech has formally implemented 340B contract pharmacy restrictions for hospitals.
Drugmaker Genentech has formally issued contract pharmacy restrictions after it gave some 340B hospitals advance notice last month of its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Adds Cancer Drug to Contract Pharmacy Restriction Policy

Drug manufacturer AbbVie recently added a cancer medication to its 340B contract pharmacy restrictions for hospitals.
Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Contract Pharmacies Have Proliferated, Conservative Group Says, Citing Data from Pharma-Funded Think Tank

A Paragon Health Institute analysis found the share of 340B contract pharmacies per covered entity has increased in recent years.
Active 340B contract pharmacies reached 17,250 in 2024, according to a conservative think tank using data collected by another group funded by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report